Press Releases

Tate & Lyle PLC was informed on 14 November 2003 that Barclays PLC and its subsidiaries held a material interest in 30,392,920 ordinary shares in Tate & Lyle PLC, which is a notifiable interest under Section 199 of the Companies Act 1985, being 6.30 per cent. of the nominal value of the relevant...

Tate & Lyle PLC (“Tate & Lyle”) announces that it has signed an agreement for the sale of its Molasses business to W&R Barnett Ltd. The consideration is £67 million payable in cash, subject to closing adjustments for net cash and working capital. The proceeds will be used to reduce Tate & Lyle’s net...

Tate & Lyle PLC (the “Company”) announces that Paul Forman has been appointed as a Non-Executive Director and a member of the Audit, Remuneration and Nominations Committees with effect from 1 January 2015.

Press release Please download the PDF for full press release. 2) 10.00am UKT presentation to analyst and investors - webcast An audio webcast of the 2012 Half Year Results Presentation will be available on www.tateandlyle.com from 10.00am UKT. A telephone dial-in facility is also provided for this...

Tate & Lyle PLC issues the following update for the year ended 31 March 2015 ahead of the announcement of full year results on 28 May 2015.

Tate & Lyle has launched Light Cane Sugar, the first light sugar that looks and tastes like Tate & Lyle’s ordinary Cane Sugar, yet contains 33 per cent fewer calories. New Tate & Lyle Light Cane sugar makes it easy for people who want to reduce their daily intake of calories. With just 11 calories...

The Trustees of the Tate & Lyle PLC Employee Benefit Trust (Number 1) (the "EBT") notified the Company on 13 June 2003 that on 13 June 2003 it had bought 550,000 Tate & Lyle PLC ordinary shares at an average price of 334.61 pence per share. By virtue of their interests in the Tate & Lyle 2000...

Before entering its closed period for the year ending 31 March 2004 and prior to meeting with stockbrokers’ analysts, Tate & Lyle issues the following routine trading update. The preliminary announcement of results for the year ending 31 March 2004 will be made on 3 June 2004. Since the update on 28...

London, August 18 2015 – Tate & Lyle Ventures announces a $2 million investment in Evolve BioSystems, Inc. a microbiome spin-out company from the University of California at Davis.

Tate & Lyle announces that it has entered into a contract manufacturing agreement with California based Amyris, Inc. Under this agreement, Tate & Lyle will produce farnesene at its facilities in Decatur, Illinois. The product will be owned and distributed by Amyris. "We are delighted to be working...